Champions Biotechnology, Inc. Announces Resignation of Mark Schonau, Champions’ Chief Financial Officer
Baltimore, MD – January 14, 2011 – Champions Biotechnology, Inc. (OTC Bulletin Board: CSBR), a company with a predictive translational platform aimed at accelerating the development and enhancing the value of oncology drugs, announced today the resignation of Mark Schonau, Champions’ Chief Financial Officer.
Mr. Schonau indicated that he has no disagreements with management and has resigned to pursue other opportunities. Champions is seeking chief financial officer candidates and intends to complete the search in the near future.